Single-dose pharmacokinetics, safety, and tolerability of modified-release formulations of lersivirine in healthy subjects

Clin Pharmacol Drug Dev. 2014 Nov;3(6):472-6. doi: 10.1002/cpdd.117. Epub 2014 May 26.

Authors

Manoli Vourvahis¹, Ronnie Wang², Laure Mendes da Costa³, Cunshan Wang², Barry Weatherley⁴, Geoffrey Mukwaya¹, Margaret Tawadrous², Jayvant Heera²

Affiliations

¹ Pfizer Global Research and Development, New York, NY, USA.
² Pfizer Global Research and Development, Groton, CT, USA.
³ Pfizer Clinical Research Unit, Brussels, Belgium.
⁴ Pfizer Global Research and Development, Sandwich, Kent, UK.

PMID: 27129121
DOI: 10.1002/cpdd.117

No abstract available

Keywords: bioavailability; food; lersivirine; modified-release; pharmacokinetics.